Cumberland Pharmaceuticals Inc
CPIX· Nasdaq
CPIXCumberland Pharmaceuticals Inc
Filed May 4, 2012 · 10-Q · 34 days after period end · 0001193125-12-212336
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $10.26M | $10.67M |
| Net Income | $423.21K | $721.16K |
| EPS Diluted | $0.02 | $0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 4, 2012 · 34 d after period end
